Logo image of ATAI

ATAI BECKLEY NV (ATAI) Stock Fundamental Analysis

USA - NASDAQ:ATAI - NL0015000DX5 - Common Stock

4.025 USD
-0.1 (-2.54%)
Last: 11/14/2025, 10:41:09 AM
Fundamental Rating

3

ATAI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. While ATAI has a great health rating, there are worries on its profitability. ATAI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ATAI had negative earnings in the past year.
ATAI had a negative operating cash flow in the past year.
In the past 5 years ATAI always reported negative net income.
In the past 5 years ATAI always reported negative operating cash flow.
ATAI Yearly Net Income VS EBIT VS OCF VS FCFATAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

The Return On Assets of ATAI (-78.89%) is worse than 71.20% of its industry peers.
ATAI's Return On Equity of -103.85% is on the low side compared to the rest of the industry. ATAI is outperformed by 61.26% of its industry peers.
Industry RankSector Rank
ROA -78.89%
ROE -103.85%
ROIC N/A
ROA(3y)-52.42%
ROA(5y)-70.02%
ROE(3y)-67.79%
ROE(5y)-86.99%
ROIC(3y)N/A
ROIC(5y)N/A
ATAI Yearly ROA, ROE, ROICATAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATAI Yearly Profit, Operating, Gross MarginsATAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -20K -40K -60K

More info and screens

7

2. Health

2.1 Basic Checks

ATAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
ATAI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ATAI has been increased compared to 5 years ago.
The debt/assets ratio for ATAI is higher compared to a year ago.
ATAI Yearly Shares OutstandingATAI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ATAI Yearly Total Debt VS Total AssetsATAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

ATAI has an Altman-Z score of 6.03. This indicates that ATAI is financially healthy and has little risk of bankruptcy at the moment.
ATAI has a better Altman-Z score (6.03) than 79.58% of its industry peers.
There is no outstanding debt for ATAI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.03
ROIC/WACCN/A
WACC7.54%
ATAI Yearly LT Debt VS Equity VS FCFATAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

ATAI has a Current Ratio of 4.02. This indicates that ATAI is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 4.02, ATAI is doing good in the industry, outperforming 62.83% of the companies in the same industry.
A Quick Ratio of 4.02 indicates that ATAI has no problem at all paying its short term obligations.
ATAI's Quick ratio of 4.02 is fine compared to the rest of the industry. ATAI outperforms 64.40% of its industry peers.
Industry RankSector Rank
Current Ratio 4.02
Quick Ratio 4.02
ATAI Yearly Current Assets VS Current LiabilitesATAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

ATAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.50%.
Looking at the last year, ATAI shows a decrease in Revenue. The Revenue has decreased by -1.91% in the last year.
ATAI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -75.28% yearly.
EPS 1Y (TTM)-72.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.11%
Revenue 1Y (TTM)-1.91%
Revenue growth 3Y-75.28%
Revenue growth 5YN/A
Sales Q2Q%163.37%

3.2 Future

ATAI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.19% yearly.
ATAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 236.62% yearly.
EPS Next Y45.22%
EPS Next 2Y23.88%
EPS Next 3Y13.75%
EPS Next 5Y14.19%
Revenue Next Year355.42%
Revenue Next 2Y-36.68%
Revenue Next 3Y18.97%
Revenue Next 5Y236.62%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ATAI Yearly Revenue VS EstimatesATAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
ATAI Yearly EPS VS EstimatesATAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2 3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATAI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATAI Price Earnings VS Forward Price EarningsATAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATAI Per share dataATAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as ATAI's earnings are expected to grow with 13.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.88%
EPS Next 3Y13.75%

More info and screens

0

5. Dividend

5.1 Amount

ATAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATAI BECKLEY NV

NASDAQ:ATAI (11/14/2025, 10:41:09 AM)

4.025

-0.1 (-2.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-11 2025-11-11/bmo
Earnings (Next)03-16 2026-03-16/amc
Inst Owners13.93%
Inst Owner Change10.74%
Ins Owners2.66%
Ins Owner Change88.24%
Market Cap949.78M
Revenue(TTM)308.00K
Net Income(TTM)-149.27M
Analysts83.53
Price Target12.35 (206.83%)
Short Float %7.44%
Short Ratio2.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.25%
Min EPS beat(2)-17.64%
Max EPS beat(2)17.15%
EPS beat(4)1
Avg EPS beat(4)-15.72%
Min EPS beat(4)-62.27%
Max EPS beat(4)17.15%
EPS beat(8)4
Avg EPS beat(8)10%
EPS beat(12)7
Avg EPS beat(12)5.89%
EPS beat(16)9
Avg EPS beat(16)-5.32%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.31%
PT rev (3m)10.1%
EPS NQ rev (1m)-5.73%
EPS NQ rev (3m)-11.73%
EPS NY rev (1m)-2.33%
EPS NY rev (3m)-5.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.54%
Revenue NY rev (3m)59.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3083.7
P/FCF N/A
P/OCF N/A
P/B 6.61
P/tB 6.77
EV/EBITDA N/A
EPS(TTM)-0.69
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS0
BVpS0.61
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -78.89%
ROE -103.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.42%
ROA(5y)-70.02%
ROE(3y)-67.79%
ROE(5y)-86.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 830.23%
Cap/Sales 2024.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.02
Quick Ratio 4.02
Altman-Z 6.03
F-Score2
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)268.35%
Cap/Depr(5y)673.01%
Cap/Sales(3y)220.74%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.11%
EPS Next Y45.22%
EPS Next 2Y23.88%
EPS Next 3Y13.75%
EPS Next 5Y14.19%
Revenue 1Y (TTM)-1.91%
Revenue growth 3Y-75.28%
Revenue growth 5YN/A
Sales Q2Q%163.37%
Revenue Next Year355.42%
Revenue Next 2Y-36.68%
Revenue Next 3Y18.97%
Revenue Next 5Y236.62%
EBIT growth 1Y18.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year0.75%
EBIT Next 3Y-16.28%
EBIT Next 5Y-3.12%
FCF growth 1Y21.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.11%
OCF growth 3YN/A
OCF growth 5YN/A

ATAI BECKLEY NV / ATAI FAQ

What is the fundamental rating for ATAI stock?

ChartMill assigns a fundamental rating of 3 / 10 to ATAI.


What is the valuation status for ATAI stock?

ChartMill assigns a valuation rating of 0 / 10 to ATAI BECKLEY NV (ATAI). This can be considered as Overvalued.


What is the profitability of ATAI stock?

ATAI BECKLEY NV (ATAI) has a profitability rating of 0 / 10.


Can you provide the financial health for ATAI stock?

The financial health rating of ATAI BECKLEY NV (ATAI) is 7 / 10.